^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    NYU Langone Health

    i
    Other names: NYU Langone Health New York | New York University Langone Health
    Related tests:
    Evidence

    News

    over1year
    NYU Langone Health gets FDA clearance for solid tumor gene sequencing test (Precision Oncology News)
    "NYU Langone Health said on Thursday that it has received 510(k) clearance from the US Food and Drug Administration for its Genome PACT genetic test for solid tumors...Genome PACT — short for profiling of actionable cancer targets — uses next-generation sequencing to detect cancer-linked mutations in 607 genes in tumor cells in order to match patients with approved treatments targeting their specific disease-causing mutations."
    FDA event
    |
    NYU Langone Genome PACT assay